Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.

about

Plasmodium TatD-Like DNase Antibodies Blocked Parasite Development in the Mosquito Gut.

P2860

Q55066826-B6B893C7-D89C-4617-89B7-62A45DECB814

P2860

Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.

Item

http://www.wikidata.org/entity/Q41989340

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of a Plasmodium-spe ...... on-blocking vaccine candidate.

@en

type

Item

label

Evaluation of a Plasmodium-spe ...... on-blocking vaccine candidate.

@en

prefLabel

Evaluation of a Plasmodium-spe ...... on-blocking vaccine candidate.

@en

P1476

Evaluation of a Plasmodium-spe ...... on-blocking vaccine candidate.

@en

P2093

Aarti Ramanathan

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Parzych

http://www.w3.org/2001/XMLSchema#string

James M Burns

http://www.w3.org/2001/XMLSchema#string

P2860

Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission

Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults

Plasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes.

Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains

Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.

P31

scholarly article

P356

10.1128/IAI.00486-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kazutoyo Miura

Carole A Long

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28993460

http://www.w3.org/2001/XMLSchema#string

P932

5736822

http://www.w3.org/2001/XMLSchema#string

Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.

about

P2860

P2860

Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932